Professional Experience Placement (PEP)
Students will be allocated PEP within individual health care agencies. Students must be available 5 days a week (40 hours) during the allocated PEP, and must be prepared to undertake a range of shifts – morning, evening and nightshift, which may include weekends, as per roster provided by the healthcare agency. Students may be expected to relocate and are expected to travel to where PEP is available. To be eligible to undertake PEP, all students must be ‘Verified’ as meeting College of Health and Medicine PEP Safety in Practice Compliance as per the Course Entry Requirements. Students who cannot or do not comply with these requirements will not be allocated PEP and therefore will not be able to complete this unit.
PEP dates MAY differ from University of Tasmania calendar semester dates.
Introduction
CSA306 (Therapeutics in Practice 3B) is designed to build upon your existing knowledge of pharmacology, physiology, microbiology and evidence-based health, in order to develop the clinical knowledge and skills necessary to deliver pharmaceutical care. The unit covers the pathophysiology and therapeutic management of common diseases. In CSA306, specific topics include hepatology, neurology, pain, psychiatry, gastroenterology and rheumatology. An emphasis is placed on the application of knowledge to evaluate and advise upon pharmacotherapy in clinical situations. Although CSA306 and CSA322 (Therapeutics in Practice 3A) are separate units, the learning derived from one is complementary to the other. CSA306 carries a weighting of 12.5% (i.e. 12.5 credit points).
Summary
| Unit name | Therapeutics in Practice 3B |
| Unit code | CSA306 |
| Credit points | 12.5 |
| College/School | Health School of Pharmacy and Pharmacology |
| Discipline | Pharmacy |
| Coordinator | Mrs Kendall Stephens |
| Available as an elective? | No |
| Delivered By | University of Tasmania |
| Level | Advanced |
Availability
Specific information on 2027 unit availability will be available in August
Learning Outcomes
- Outline the common presenting features of acute and chronic conditions/diseases.
- Identify medication-related problems and/or health issues that may actually or potentially impact the patient
- Design patient-centred therapeutic plans that incorporate appropriate monitoring strategies and non-pharmacological interventions to enhance health outcomes
- Interpret diagnostic and clinical data to inform and optimise patient care
Fee Information
2027 fee information will be available in August.
Requisites
Prerequisites
CSA322Co-requisites
CSA357Teaching
| Teaching Pattern | 4 hours self directed online learning activities weekly, 2 hour workshops weekly, 5 x 3 hours of simulation hospital based clinical rounds throughout the study period. 1 hour online seminar weekly |
|---|---|
| Assessment | In-workshop clinical case assessment (30%)|Mid-semester written test (30%)|End of Semester written Exam (40%) |
| Timetable | View the lecture timetable | View the full unit timetable |
Textbooks
| Required |
Required readings will be listed in the unit outline prior to the start of classes. |
|---|---|
| Recommended | Students are recommended to view the following online resources via the library website: DiPiro et al. Pharmacotherapy: A Pathophysiologic Approach. McGraw-Hill Medical (12th Edition) In addition to the recommended online textbook, students will be signposted to a variety of other material relevant to the area of study. Links will be provided to these materials through MyLO where possible. Most of these materials will be available online, either freely accessible or through the University library. Students will also find the following e-resources (available via EPOCH) highly valuable for CSA306 and related units: |
The University reserves the right to amend or remove courses and unit availabilities, as appropriate.